SCHEMBL13313232

SCHEMBL13313232

COCCCCOc1ccc(F)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.54
USP2 O75604 1/20 0.54
HPGD P15428 1/20 0.54
DRD2 P14416 2/20 0.53
DRD4 P21917 2/20 0.53
DRD3 P35462 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
KDM4E B2RXH2 1/20 0.53
CYP1A2 P05177 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C19 P33261 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
LMNA P02545 2/20 0.51
MEN1 O00255 1/20 0.51
HTT P42858 1/20 0.51
KMT2A Q03164 1/20 0.51
HRH3 Q9Y5N1 1/20 0.50
TSHR P16473 1/20 0.47
FAAH O00519 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13313217 0.96 DRD2 (0.53) ALDH1A1USP2HPGDDRD2DRD4
SCHEMBL11965490 0.89 CYP1A2 (0.58) ALDH1A1USP2HPGDDRD2DRD4
SCHEMBL10338308 0.89 MEN1 (0.60) ALDH1A1USP2HPGDDRD2DRD4
SCHEMBL14232126 0.83 CYP2D6 (0.53) ALDH1A1USP2HPGDDRD2DRD4
SCHEMBL14926622 0.83 CYP2D6 (0.53) ALDH1A1USP2HPGDDRD2DRD4
SCHEMBL5169009 0.83 NR5A1 (0.62) ALDH1A1USP2HPGDDRD2DRD4
SCHEMBL4270834 0.82 TSHR (0.64) ALDH1A1USP2HPGDDRD2DRD4
SCHEMBL13313234 0.82 MAPT (0.56) ALDH1A1HPGDDRD2DRD4DRD3
SCHEMBL9114592 0.81 CYP1A2 (0.63) ALDH1A1USP2HPGDDRD2DRD4
SCHEMBL24398901 0.81 NR5A1 (0.66) CYP1A2CYP2D6CYP2C19TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7728023-B2 Indole compound and use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-06-01 US disclosed
US-7728023-B2 Indole compound and use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-06-01 US disclosed
US-20080188532-A1 Indole Compound and Use Thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2008-08-07 US disclosed
US-20080188532-A1 Indole Compound and Use Thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2008-08-07 US disclosed
EP-1852420-A1 INDOLE COMPOUND AND USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2007-11-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188532-A1 Indole Compound and Use Thereof CYSLTR1, LTC4S, IDO1 ALDH1A1 1805/4885USP2 2853/4885HPGD 287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.